Fennec Pharmaceuticals (FENC) Revenue (2020 - 2025)

Fennec Pharmaceuticals (FENC) posted Revenue of $13.8 million for Q4 2025, up 10.55% on a QoQ basis from $12.5 million in Q3 2025, and up 73.84% year-over-year from $7.9 million in Q4 2024.

Fennec Pharmaceuticals (FENC) Revenue (2020 - 2025) Analysis & Trends

Fennec Pharmaceuticals' Revenue history runs 4 years deep, the most recent figure standing at $13.8 million for Q4 2025.

  • Quarterly Revenue rose 73.84% year-over-year to $13.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.6 million (down 6.09% YoY) and the FY2025 annual result came in at $44.6 million, down 6.09% from the prior year.
  • Revenue was $13.8 million for Q4 2025 at Fennec Pharmaceuticals, up from $12.5 million in the prior quarter.
  • Across five years, Revenue topped out at $25.4 million in Q1 2024 and bottomed at $1.7 million in Q1 2023.
  • A 3-year average of $9.5 million and a median of $8.3 million in 2024 frame the typical range for Revenue.
  • Annual changes were most pronounced in 2024 — Revenue jumped 1413.24% — and 2025, when it tumbled 65.52%.
  • Fennec Pharmaceuticals' Revenue stood at $9.7 million in 2023, then dropped by 18.59% to $7.9 million in 2024, then soared by 73.84% to $13.8 million in 2025.
  • Business Quant data shows FENC's Revenue at $13.8 million in Q4 2025, $12.5 million in Q3 2025, and $9.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Fennec Pharmaceuticals 287.77 Mn 250.98 Mn 12.01 Mn 13.78 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 13.78 Mn
Sep 30, 2025 12.46 Mn
Jun 30, 2025 9.65 Mn
Mar 31, 2025 8.75 Mn
Dec 31, 2024 7.93 Mn
Sep 30, 2024 6.97 Mn
Jun 30, 2024 7.26 Mn
Mar 31, 2024 25.38 Mn
Dec 31, 2023 9.74 Mn
Sep 30, 2023 6.52 Mn
Jun 30, 2023 3.33 Mn
Mar 31, 2023 1.68 Mn
Dec 31, 2020 200,000.00